Back to search

Article

High dose everolimus promotes a pro-inflammatory phenotype and facilitates the epithelial to mesenchymal transition of primary bronchial epithelial cells isolated from cystic fibrosis patients.

2020-08-13

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Lung transplantation is still the best therapeutic option for cystic fibrosis (CF) patients, but, unfortunately, immunosuppressive therapies, often employed at high dosages to avoid acute rejection, may induce severe complications. In particular, patients treated with high dose of mammalian target of rapamycin inhibitors (mTOR-Is) may experience lung fibrosis (i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
179b2485-ab7c-5e58-9d44-017c341609ed
DOI
10.21203/rs.3.rs-46751/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High dose everolimus promotes a pro-inflammatory phenotype and facilitates the epithelial to mesenchymal transition of primary bronchial epithelial cells isolated from cystic fibrosis patients.DOI 10.21203/rs.3.rs-46751/v1
Select a neighboring publication to make it the new centre.